Robert Potashnick Insider Profile
4 Followers
Robert Potashnick, Interim CFO at Envoy Medical, holds 212.50K shares in Envoy Medical (Ticker: COCH), holds 510.00K shares in FOXO Technologies (Ticker: FOXO). Most recently, Robert Potashnick Bought ― shares of Envoy Medical on Feb 17, 2026 for an estimated value of $85.00K.
Robert Potashnick has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Potashnick holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Potashnick
Robert Potashnick's Trading History
Envoy Medical
Feb 17, 2026
Interim CFO
Informative Buy
85.00K
$158.31K
FOXO Technologies
Sep 16, 2022
Chief Financial Officer
Uninformative Buy
―
$30.60K
List of latest transactions for each holding click on a transaction to see Robert Potashnick's performance on stock
You May Also Like
Robert Potashnick insider profile FAQ
What is the percentage of profitable transactions made by Robert Potashnick?
The percentage of profitable transactions made by Robert Potashnick is ―.
What is the average return per transaction made by Robert Potashnick?
The average return per transaction made by Robert Potashnick is ―.
What stocks does Robert Potashnick hold?
Robert Potashnick holds: COCH, FOXO stocks.
What was Robert Potashnick’s latest transaction?
Robert Potashnick latest transaction was an Informative Buy of $85.00K.
What was Robert Potashnick's most profitable transaction?
Robert Potashnick’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Potashnick's role in Envoy Medical?
Robert Potashnick's role in Envoy Medical is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.